Top Markets
Coin of the day
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.

Steminent Biotherapeutics Inc.

7729
Kedudukan dalam Saham #18871
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to... Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.
Harga Saham
$2.51
Modal Pasaran
$183.34M
Perubahan (1 hari)
0.90%
Perubahan (1 tahun)
91.17%
Negara
TW
Perdagangan Steminent Biotherapeutics Inc. (7729)

Kategori

Harga 7729 dengan permodalan pasaran b
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
7729
$2.51
Modal pasaran bagi Steminent Biotherapeutics Inc.(7729)
Modal Pasaran: $183.34M
Sehingga August 2026, Steminent Biotherapeutics Inc. mempunyai modal pasaran sebanyak $183.34M. Ini menjadikan Steminent Biotherapeutics Inc. syarikat ke-18871st paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Steminent Biotherapeutics Inc. dari 2024 hingga 2026
7729 berbanding dengan 5 teratas yang paling popular stocks
Harga 7729 Aset B Pasaran B Hasilnya
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$70,028.01 $183.34M
$5.117T +2,791,035.64%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$62,827.23 $183.34M
$4.591T +2,504,031.11%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$56,418.76 $183.34M
$4.123T +2,248,606.02%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$50,288.84 $183.34M
$3.675T +2,004,283.43%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$38,273.95 $183.34M
$2.797T +1,525,400.90%